Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
University of Florida
City of Hope Medical Center
Institut Curie
Brigham and Women's Hospital
Washington University School of Medicine
Sichuan Enray Pharmaceutical Sciences Company
University of Alabama at Birmingham
Instituto do Cancer do Estado de São Paulo
University of Pittsburgh
Institut de Cancérologie de Lorraine
Xencor, Inc.
NRG Oncology
Abramson Cancer Center at Penn Medicine
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
NYU Langone Health